Thermo Fisher Scientific Inc (TMO)
Stock Health Score
Potential Growth Score
Dividend Score
Company Profile
Thermo Fisher Scientific Inc provides life sciences solutions analytical instruments specialty diagnostics and laboratory products and biopharma services in the North America Europe AsiaPacific and internationally The companys Life Sciences Solutions segment offers reagents instruments and consumables for biological and medical research discovery and production of drugs and vaccines as well as diagnosis of infections and diseases and solutions include biosciences genetic sciences and bio production to pharmaceutical biotechnology agricultural clinical healthcare academic and government markets Its Analytical Instruments segment provides instruments consumables software and services for pharmaceutical biotechnology academic government environmental and other research and industrial markets as well as clinical laboratories The companys Specialty Diagnostics segment offers liquid readytouse and lyophilized immunodiagnostic reagent kits as well as calibrators controls protein detection assays and instruments immunodiagnostics develops manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy asthma and autoimmune diseases dehydrated and prepared culture media collection and transport systems instrumentation and consumables human leukocyte antigen typing and testing for organ transplant market and healthcare products Its Laboratory Products and Biopharma Services segment provides laboratory products research and safety market channel and pharma services and clinical research It offers products and services through a direct sales force customerservice professionals electronic commerce and thirdparty distributors under Thermo Scientific Applied Biosystems Invitrogen Fisher Scientific Unity Lab Services and Patheon and PPD Thermo Fisher Scientific Inc was founded in 1956 and is headquartered in Waltham Massachusetts
Dividend Summary
Last Payment | Aug 06, 1993 | Next Expected | Nov 30, 2024 |
Amount | $0.1450 | Probability | 25.0% |
Current Yield | 0.36% | Previous Yield | 0.00% |
Key Metrics
Beta | 0.79 | P/E Ratio | 32.82 |
Market Cap | $200.45B |
AI Analysis